Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Reference:EU EMA/786433/2022 Annex V – to guidance for the conduct of good clinical practice inspections – Phase I units 15-Nov-2022 2.5-002: Difference between revisions

From GxPlex

Jump to: navigation, search
m 1 revision imported
imported>GxPlexBot
Import from GxPlex Excel
Line 4: Line 4:
|RefDocPart=2.5
|RefDocPart=2.5
|RefLanguage=EN
|RefLanguage=EN
|RefTagsEN=
|RefTags=TAG-00018-Inv-die ++ TAG-00017-Spo-die ++ TAG-00340-Req-nfo
|RefTagsOriginal=
|RefModule=4
|RefTagsFR=
|RefUnit=4.5.2
}}
}}


Line 14: Line 14:
|-
|-
! colspan="2" class="gplx-infobox-header" | Reference Details
! colspan="2" class="gplx-infobox-header" | Reference Details
|-
! Module
| Module 4 — Unit 4.5.2
|-
|-
! Scope
! Scope
Line 30: Line 33:
|  
|  
|-
|-
! Tags (EN)
! Tags
|  
| [[Glossary:TAG-00018-Inv-die|Investigator]], [[Glossary:TAG-00017-Spo-die|Sponsor]], [[Glossary:TAG-00340-Req-nfo|Requirements]]
|-
! Tags (original language)
|
|-
! Tags (FR)
|  
|-
|-
! Comment
! Comment

Revision as of 17:29, 15 July 2026



Document information
Reference EU EMA/786433/2022

Annex V – to guidance for the conduct of good clinical practice inspections – Phase I units 15-Nov-2022

Validity area EU
Scope(s) G
Document name EMA/786433/2022

Annex V – to guidance for the conduct of good clinical practice inspections – Phase I units

Version / Revision 15-Nov-2022
Status Current
Document type Official guideline
Language(s) EN
Description EMA/786433/2022

Annex V – to guidance for the conduct of good clinical practice inspections – Phase I units

Official source Official link
Restricted access No
Submitted by Florian Adragna
Contributors


Reference Details
Module Module 4 — Unit 4.5.2
Scope G
Document part 2.5
Language EN
Original entry by Florian Adragna
Contributors
Tags Investigator, Sponsor, Requirements
Comment Repeated entry: 4.5.2 ++ 2.4.0

Personnel requirements: investigator-sponsor relationship

Content

2.5. Personnel Points to consider: […] • Relationship of the Investigator with the Sponsor company. […]